Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Convertible Debt (2024 - 2025)

Biofrontera (BFRI) has 2 years of Convertible Debt data on record, last reported at $4.5 million in Q3 2025.

  • For Q3 2025, Convertible Debt changed N/A year-over-year to $4.5 million; the TTM value through Sep 2025 reached $4.5 million, changed N/A, while the annual FY2024 figure was $4.1 million, N/A changed from the prior year.
  • Convertible Debt reached $4.5 million in Q3 2025 per BFRI's latest filing, up from $4.3 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $4.5 million in Q3 2025 and bottomed at $4.1 million in Q4 2024.